Associate / Legal advisor

Aura BRAUN

Areas of expertise

Aura practices in the following main areas :

  • Advice to healthcare companies on regulatory matters (healthcare products, relationship between healthcare industries and healthcare professionals …)
  • Personal data protection
  • Drafting and amending of agreements
Professional practice

Aura is a lawyer, admitted to the Paris Bar. Aura joined DELSOL Avocats in 2021 after other experiences in lawyer practices specialized in healthcare law.

Aura has been designated as a Leading associate in Healthcare & life sciences by Legal 500 in 2026.

Education
  • CAPA (2017),
  • Master II Droit de l’industrie de la santé (Université Paris V Descartes – 2014)
Languages

French, English

Legal 500 EMEA 2026 rankings

DELSOL Avocats is proud to be ranked in 11 Legal 500 EMEA 2026 categories : In addition to these collective

PRESS RELEASE – DELSOL Avocats advises AGORiA Santé on obtaining the CNIL’s 1st authorization to combine biology and SNDS data

DELSOL Avocats has advised the AGORiA Santé consortium, in partnership with BIOGROUP, on obtaining the CNIL’s (French data protection authoritys)

Contributions of the Economic Life Simplification Bill to the Legal Framework for Health-Related Research

The Draft Economic Life Simplification Bill, passed by the French National Assembly on June 17th, 2025, seeks to promote French

DELSOL Avocats advised the Centre Hospitalier Intercommunal Toulon – La Seyne-sur-Mer on the takeover of the Sainte-Marguerite clinic by Almaviva Santé

DELSOL Avocats advised the Centre Hospitalier Intercommunal Toulon – La Seyne-sur-Mer (CHITS) on the takeover of the Sainte-Marguerite clinic in

The French health data hub “SNDS”: new databases added

The decree of February 7, 2025, published in the Official Journal on March 1, expands the list of databases included

The inference capacity of AI systems: key element of their definition

On February 6, 2025, the European Commission published guidelines on the notion of “AI system” ] (“Guidelines“) as defined by

The EU Regulates Artificial Intelligence : New European Commission Guidelines on Prohibited Practices

Artificial intelligence (“AI”) is at the heart of medical and technological innovations, but its fast development raises significant ethical and

Towards a change in evaluation methods for professional digital medical devices?

Digital medical devices (hereinafter “DMD”), particularly those incorporating artificial intelligence (hereinafter “AI”) technologies, are developing rapidly in the healthcare sector.

DELSOL Avocats assisted RHISA for her authorisation from the CNIL regarding a medical image data warehouse for research purposes after anonymisation

Jeanne BOSSI MALAFOSSE, partner, and Aura BRAUN, associate, advised RHISA in drafting the application for authorisation from the CNIL (French